Skip to main content

1 July 2025

Last updated: Tuesday 1 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The outlook for gene editing in treating disease

Sunday 28 November 2021

Interviewee/Contributor

Paula Salmikangas and Björn Carlsson and Steffen Thirstrup

Organisation

NDA Group

Organisations

Novasecta
Celtic Pharma Holdings
Destiny Pharma Plc
Sofinnova Partners
Innovative Molecules GmbH
Nextech Invest Ltd
ETH Zürich
BC Platforms AG
Society for Family Health Nigeria
Fraunhofer Institute for Systems and Innovation Research

Interviewees and Contributers

Iain McGill
Dr Richard Jarman
Dominique Costantini
Pierluigi Paracchi
Greg Mullen
Ilka Wicke
Ulrich Mahr
Thomas G Evans
Ruth McKernan
Ceri Wiggins and Jon Moore

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form